BioSpace News Archive

Immuno-oncology candidate, GB1275, advances to clinic for selected solid tumor types

Health Canada officials will provide an update on important steps toward National Pharmacare.

Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 (DNM2) for the treatment of Centronuclear Myopathies (CNM)

A new study found that joint replacement patients who go home the day of surgery are as happy—if not happier—than those who remain in the hospital.

The 20th International Conference on Alzheimer’s Drug Discovery, a two-day interdisciplinary forum to be held September 16-17, 2019 in Jersey City, NJ, will bring together 20 top researchers to present a diversity of approaches and the latest on innovative treatments and diagnostics for Alzheimer’s disease, related dementias and cognitive aging.

13th Annual CBI Forum on Transparency & Aggregate Spend at 11:45 a.m. on August 13, 2019 in Washington, DC.

Innovator of the Month award from Senator Chris Murphy (D-Conn.) at an open house event held on August 7, 2019 at the company’s newly expanded offices in New Haven, Conn.